Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of open-label melperone in psychosis associated with Parkinson's disease
2007-002874-75Phase 2Terminated
- Sponsor
- Ovation Pharmaceuticals
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melperone, sponsored by Ovation Pharmaceuticals. Primary endpoint: Assessment of effectiveness. Started Jan 2008; status: terminated.
02
Drugs
melperone
Beyond the preview
Go deeper on 2007-002874-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002874-75.